7.7.3 BPL Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin
(2012-2017)
7.7.4 Main Business/Business Overview
7.8 Kedrion
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Human Coagulation Factor VIII Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Kedrion Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross
Margin (2012-2017)
7.8.4 Main Business/Business Overview
8 Human Coagulation Factor VIII Manufacturing Cost Analysis
8.1 Human Coagulation Factor VIII Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Human Coagulation Factor VIII
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Human Coagulation Factor VIII Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Human Coagulation Factor VIII Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Human Coagulation Factor VIII Market Forecast (2017-2022)
12.1 Global Human Coagulation Factor VIII Capacity, Production, Revenue Forecast (2017-2022)